Organ-on-Chip Market Set to Achieve USD 950 million by 2030, Growing at a Robust 40% CAGR: MarkNtel Advisors

Market Overview:

MarkNtel Advisors has released a new report that highlights the strong growth trajectory of the Organ-on-Chip Market, The Global Organ-on-Chip Market size was valued at around USD 126 million in 2024 and is projected to reach USD 950 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 40% during the forecast period (2025-30). Various factors are attributed to the growth of the market like growth in automobile production, growing focus on lightweight sustainable materials, rising demand for luxury customized interiors, increasing focus on safety standards, and the adoption of Advanced Driver Assistance Systems (ADAS). The report provides valuable insights into the drivers, trends, and challenges shaping the future of the Organ-on-Chip Market. It offers an in-depth look at the key players, geographical performance, and the segments leading the charge in market share.

Industry Outlook Forecasts:

Forecast Period: 2025-2030
Market Size in 2024: USD 126 million
CAGR (2025-2030): 40%

Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/organ-on-chip-market.html

Global Organ-on-Chip Market Segmentation Breakdown:

By Model Type
- Organ-Based Model- Market Size Forecast 2020-2030, USD Million
- Disease-Based Model- Market Size Forecast 2020-2030, USD Million
By Material
- Polydimethylsiloxane (PDMS)- Market Size Forecast 2020-2030, USD Million
- Polymer- Market Size Forecast 2020-2030, USD Million
- Glass- Market Size Forecast 2020-2030, USD Million
By Solution
- Products- Market Size Forecast 2020-2030, USD Million
  - Instruments- Market Size Forecast 2020-2030, USD Million
  - Consumables Accessories - Market Size Forecast 2020-2030, USD Million
  - Software- Market Size Forecast 2020-2030, USD Million
- Services- Market Size Forecast 2020-2030, USD Million
  - Custom Services- Market Size Forecast 2020-2030, USD Million
  - Standard Services- Market Size Forecast 2020-2030, USD Million
- By Organ Type
  - Liver-Market Size Forecast 2020-2030, USD Million
  - Intestine-Market Size Forecast 2020-2030, USD Million
  - Kidney-Market Size Forecast 2020-2030, USD Million
  - Lung-Market Size Forecast 2020-2030, USD Million
  - Heart-Market Size Forecast 2020-2030, USD Million
  - Other organs

Based on organ type, the Liver segment leads the global market. It holds approx. 30% of the total market value. Their extensive use in liver disease studies, toxicity testing, and drug metabolism contributes to the high percentage share.

By Application
- Toxicology Research-Market Size Forecast 2020-2030, USD Million
- Drug Discovery-Market Size Forecast 2020-2030, USD Million
- Physiological Model Development-Market Size Forecast 2020-2030, USD Million
- Stem cell Research-Market Size Forecast 2020-2030, USD Million
- Tissue regeneration and regenerative Medicines-Market Size Forecast 2020-2030, USD Million
- Others
By End User
- Pharmaceutical and Biotechnology Companies-Market Size Forecast 2020-2030, USD Million
- Cosmetics Industry-Market Size Forecast 2020-2030, USD Million
- Academic and Research Institutes-Market Size Forecast 2020-2030, USD Million
- Others

Based on end users, pharmaceutical and biotechnology lead the market. It holds approx. 73% market share. This growth is because of their considerable use of OoC systems for drug discovery, testing of toxicity, and the modeling of diseases.

Geographical Growth Insights:

By Region

North America
South America
Europe
The Middle East Africa
Asia-Pacific

Out of them, North America dominates the Global Organ-on-Chip Market. It holds approx. 52% market share. The region is supported by robust investments in biomedical research, superior infrastructure, and the presence of major industry players.

MarkNtel Advisors Highlights Key Market Drivers for Organ-on-Chip Market:

Growing Demand for Alternatives to Animal Testing in Drug Discovery – The worldwide market for organ-on-chip technology is driven by the growing need for alternatives to animal testing in drug discovery. To enhance safety efficacy evaluations and lessen the ethical issues surrounding animal testing regulatory organizations like the FDA and EMA promote the use of sophisticated in-vitro models. The FDA Modernization Act 2.0. passed by the USA government in the year 2022, will greatly decrease the use of animal drug testing by promoting the use of substitute techniques like organ-on-chips. Precise simulation of human organ function through systems such as the liver and lung on chips offers increased predictive accuracy of drug toxicity and metabolism studies. For instance; Emulate's liver on a chip has been widely utilized to predict hepatotoxicity in candidates for drugs reducing dependence on animal models. This shows how Organ-On-Chip technology is changing the scenario of preclinical testing to provide ethical and cost-effective solutions for the pharmaceutical industry with alternatives to animal testing.

A Comprehensive Analysis of Leading Companies in Global Organ-on-Chip Market

Altis Biosystems, AlveoliX AG, Axosim, Bi/ond Solutions B.V, Cherry Biotech, CN-Bio, Emulate, Inc., Hesperos, Inc., Insphero, MesoBioTech, Mimetas B.V., Nortis Inc., React4Life, TARA Biosystems (Valo Health), TissUse GmbH and Others

Explore More About This Research Report @ https://www.marknteladvisors.com/research-library/organ-on-chip-market.html

Global Organ-on-Chip Industry Recent Development:

April 2024: CN Bio secured USD 21 million in Series B funding from Bayland Capital and CN Innovations Holdings Ltd. to expand its product development scaling, meeting the rising demand for organ on a chip solution and driven by improved drug RD efficiency and legislative changes like the US FDA Modernization Act 2.0.
March 2024: MIMETAS joined the Centre for Animal-Free Biomedical Translation (CPBT), which received USD134.78 million from the Dutch National Growth Fund to advance animal-free biomedical innovations.

What are the growth Opportunity driving the Global Organ-on-Chip Market?

Development of Multi-Organ-on-Chip Systems – The development of multi-organ-on-chip systems provides a big opportunity in the organ-on-chip industry. These complex models can better mimic complicated interactions between different organs by allowing more realistic simulations of human physiology. For instance, the laboratories of TissUse GmbH are already working with 2- and 4-organ chips. These systems are of particular value in the study of drug metabolism and organ toxicity across multiple systems simultaneously, which is important for the assessment of the effects of new therapies and understanding diseases like cancer and metabolic disorders. As the demand for accurate, personalized medicine increases, the multi-organ-on-chip platforms can augment drug discovery, toxicity testing, and the development of personalized treatment. This innovation is likely to bring about huge market expansion as pharmaceutical and biotech companies move toward finding more advanced testing solutions.

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Key Advantages of the Report by MarkNtel Advisors:

Accurate Revenue Projections: The report provides precise revenue estimates for the market and its key subsegments, benefiting both market leaders and new entrants.

Strategic Insights for Stakeholders: By understanding the competitive landscape, stakeholders can strategically position their businesses and develop effective go-to-market strategies.

Comprehensive Market Dynamics Analysis: The report offers valuable insights into the key drivers, restraints, challenges, and opportunities within the market, helping stakeholders make well-informed decisions.

Note: If you need additional information not included in the report, we can customize it to suit your requirements.

Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/organ-on-chip-market.html

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative quantitative research company, strive to deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

More Research Studies:

The Global Organ-on-Chip Marketsize was valued at around USD 126 million in 2024 and is projected to reach USD 950 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 40% during the forecast period (2025-30).
The Global ESG Reporting Software Marketsize was valued at around USD 0.95 billion in 2024 and is projected to reach USD 2.6 billion by 2030. Along with this, the market is estimated to grow at a CAGR of 140% during the forecast period, i.e., 2025-30.
The Global Mushroom Market size was valued at around USD 64 billionin 2024 and is projected to reach USD 99 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 40% during the forecast period, i.e., 2025-30.